Tuberculosis is one of the most common and serious infectious diseases. The number of multidrug-resistant pathogens is rising, which makes treatment more difficult. Only the quick detection of the pathogen and its possible resistance to antibiotics ensures optimal treatment and prevents the further spread of the airborne disease. Scientists, doctors, and medical device manufacturers from the Jena Research Campus InfectoGnostics are developing a new method of testing to quickly and reliably diagnose tuberculosis pathogens and their potential resistance on site. [The PDF below contains the full German press release]